Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Reem Akel"'
Autor:
Arafat Tfayli, Majd Al Assaad, Ghina Fakhri, Reem Akel, Hanine Atwi, Hady Ghanem, Fadi El Karak, Fadi Farhat, Kamal Al Rabi, Pierre Sfeir, Pierre Youssef, Ziad Mansour, Hazem Assi, Mohamad Haidar, Alain Abi Ghanem, Ibrahim Khalifeh, Fouad Boulos, Ramy Mahfouz, Bassem Youssef, Youssef Zeidan, Rachelle Bejjany, Fadlo Khuri
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8406-8411 (2020)
Abstract Multiple randomized studies have shown that combination of chemotherapy and immune checkpoint inhibitors (ICIs) leads to better response rates and survival as compared to chemotherapy alone in the advanced stage of NSCLC. Data suggesting a b
Externí odkaz:
https://doaj.org/article/d6eb58e736a745a1befdf7c504496b67
Autor:
Ghina Fakhri, Reem Akel, Ibrahim Khalifeh, Hassan Chami, Adel Hajj Ali, Majd Al Assaad, Haneen Atwi, Humam Kadara, Arafat Tfayli
Publikováno v:
SAGE Open Medicine, Vol 9 (2021)
Introduction: Programmed death ligand-1 expression has been shown to be a good predictor of response to cancer therapy with checkpoint inhibitors. Its expression varies among different tumor types and among non-small cell lung cancer patients with di
Externí odkaz:
https://doaj.org/article/656f2b02b9324c93beb6bcf5a874e17c
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 353-359 (2018)
Background: Follicular dendritic cell sarcoma (FDCS) is an extremely rare malignant tumor caused by proliferation of antigen-presenting follicular dendritic cells. The tumor most commonly arises in lymph nodes, with fewer than 30% of cases originatin
Externí odkaz:
https://doaj.org/article/9c97a08f91844dd4af90db247244acb6
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 1070-1075 (2017)
Background: Pembrolizumab is a humanized monoclonal antibody which serves to enhance the antitumor immune response by targeting programmed cell death 1 receptor. The use of pembrolizumab plus carboplatin/pemetrexed combination therapy results in impr
Externí odkaz:
https://doaj.org/article/bc6725fabcff4fbb95e937611bb6be81
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 2, Pp 456-461 (2017)
Background: Antitumor immunotherapy has become a major player in cancer therapy. Ipilimumab is a humanized monoclonal antibody against the cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), an important downregulator of T-cell activation. Ipilimum
Externí odkaz:
https://doaj.org/article/8b5e5421d7434caaa834f1d420d68f48
Autor:
Fadi Taza, Rafat Abonour, Mohammad Abu Zaid, Sandra K. Althouse, Bilal Anouti, Reem Akel, Nasser H. Hanna, Nabil Adra, Lawrence H. Einhorn
Publikováno v:
Clinical Genitourinary Cancer. 21:213-220
Publikováno v:
Journal of Palliative Medicine.
Autor:
Reem Akel, Antoine N. Saliba, Cynthia Wei, Bilal Anouti, Noelle C. Sinex, Mitchell Goldman, Sara J. Grethlein, Naveen Manchanda, Jennifer M King
Publikováno v:
Journal of Cancer Education. 37:1768-1772
Interest in an oncology career has decreased among internal medicine residents completing an inpatient hematology-oncology rotation. Over years, our institutional data at Indiana University School of Medicine reflected lower satisfaction with the onc
Autor:
Ghina Fakhri, Arafat Tfayli, Mohamad Haidar, Youssef H. Zeidan, Hazem I. Assi, Kamal Al Rabi, Ziad Mansour, Majd Al Assaad, Pierre Sfeir, Fouad Boulos, Ramy Mahfouz, Fadlo R. Khuri, Hady Ghanem, Fadi El Karak, Reem Akel, Rachelle Bejjany, Pierre Youssef, Alain Abi Ghanem, Fadi Farhat, Bassem Youssef, Hanine Atwi, Ibrahim Khalifeh
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 22, Pp 8406-8411 (2020)
Cancer Medicine, Vol 9, Iss 22, Pp 8406-8411 (2020)
Multiple randomized studies have shown that combination of chemotherapy and immune checkpoint inhibitors (ICIs) leads to better response rates and survival as compared to chemotherapy alone in the advanced stage of NSCLC. Data suggesting a benefit to
Autor:
Jennifer M, King, Reem, Akel, Antoine N, Saliba, Cynthia, Wei, Bilal, Anouti, Naveen, Manchanda, Noelle C, Sinex, Sara Jo, Grethlein, Mitchell, Goldman
Publikováno v:
Journal of cancer education : the official journal of the American Association for Cancer Education. 37(6)
Interest in an oncology career has decreased among internal medicine residents completing an inpatient hematology-oncology rotation. Over years, our institutional data at Indiana University School of Medicine reflected lower satisfaction with the onc